Liavium®-CA1 (pregabalin chewable tablets) Receive...
Category : Approval/Launch 19 May 2026Pegasus Laboratories, Inc. (Pegasus), under its registered trademark PRN® Pharmacal brand, today...
Approval Launch
Eli Lilly Launches Alzheimer’s Drug Lormalzi (Dona...
Category : Approval/Launch 14 May 2026Eli Lilly and Company has officially launched Lormalzi (donanemab) in India following marketing auth...
FDA Expands Asceniv Label to Include Pediatric Pat...
Category : Approval/Launch 6 May 2026For companies operating in niche biologics, label expansion is often more valuable than new approval...
Novartis Secures EU Approval for Rhapsido: A New O...
Category : Approval/Launch 28 April 2026The treatment landscape for chronic spontaneous urticaria (CSU) just shifted. Novartis has secured E...
Johnson & Johnson’s IMAAVY Secures FDA Priority Re...
Category : Approval/Launch 28 April 2026Johnson & Johnson has received Priority Review designation from the U.S. Food and Drug Administr...
Latest Newsletter Post
-
Helus Pharma Reports Strong Enrollm..
25 June 2026
-
Ascletis Receives FDA Clearance to..
25 June 2026
-
Advanta bioKEMIX and Resolkem Form..
25 June 2026
-
Agomab Unveils Phase 2b Study Desig..
24 June 2026
-
CureGene Doses First Patient in US..
24 June 2026
